Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy

Mathias Lutz, Andrea Worschech, Miriam Alb, Sabine Gahn, Laura Bernhard, Michael Schwab, Stefanie Obermeier, Hermann Einsele, Ulrike Kämmerer, Peter Heuschmann, Erdwine Klinker, Christoph Otto, Stephan Mielke

Blood (2015) 125 (2): 261–272.

https://doi.org/10.1182/blood-2014-09-601302

Published: 2015

Journal Articles

Men Show Significantly Higher T Lymphocyte Mediated Immune Responses Against H-Y Than Multiparous Women: Results from a Cross-Sectional Analysis in 114 Volunteer Blood Donors and Implications for Immunotherapy

Mathias Lutz, MD, Andrea Worschech, PhD, Miriam Alb, PhD, Sabine Gahn, Laura Bernhard, Michael Schwab, MD, Stefanie Obermeier, Hermann Einsele, MD, Ulrike Kämmerer, PhD, Peter Heuschmann, MD, Erdwine Klinker, MD, Christoph Otto, PhD, Stephan Mielke, MD

Blood (2014) 124 (21): 3831.

https://doi.org/10.1182/blood.V124.21.3831.3831

Published: 2014

Journal Articles

Boost and Loss Of Immune Responses Against Tumor-Associated Antigens In The Course Of Pregnancy As a Model For Immunotherapy

Mathias Lutz, Medical Student, Miriam Alb, MSc, Andrea Worschech, PhD, Sabine Gahn, MLS, Laura Bernhard, MLS, Michael Schwab, MD, Hermann Einsele, MD, Ulrike Kämmerer, PhD, Peter Heuschmann, MD, Erdwine Klinker, MD, Christoph Otto, PhD, Stephan Mielke, MD

Blood (2013) 122 (21): 4505.

https://doi.org/10.1182/blood.V122.21.4505.4505

Published: 2013

Journal Articles

Salvage Therapy with Everolimus Reduces the Severity of Treatment-Refractory Chronic Graft-Versus-Host Disease without Impairing Disease Control: A Dual Center Experience

Stephan Mielke, MD, Mathias Lutz, Medical Student, Judith Schmidhuber, Medical Student, Markus Kapp, MD, Julia Ammer, MD, Hermann Einsele, MD, Götz Ulrich Grigoleit, MD, Ernst Holler, MD, Daniel Wolff, MD

Blood (2012) 120 (21): 4173.

https://doi.org/10.1182/blood.V120.21.4173.4173

Published: 2012

Journal Articles

Immune Responses Against the Tumor-Associated Antigens WT1, MUC-1, PRAME and HER2/Neu in 114 Prospectively Screened Healthy Donors: Effects of Gender and Prior Pregnancy and Implications for Immunotherapy

Mathias Lutz, Andrea Worschech, PhD, Sabine Gahn, MLS, Laura Bernhard, MLS, Michael Schwab, MD, Hermann Einsele, MD, Ulrike Kämmerer, PhD, Peter Heuschmann, MD, Erdwine Klinker, MD, Christoph Otto, PhD, Stephan Mielke, MD

Blood (2012) 120 (21): 4115.

https://doi.org/10.1182/blood.V120.21.4115.4115

Published: 2012

NARROW

Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy

Men Show Significantly Higher T Lymphocyte Mediated Immune Responses Against H-Y Than Multiparous Women: Results from a Cross-Sectional Analysis in 114 Volunteer Blood Donors and Implications for Immunotherapy

Boost and Loss Of Immune Responses Against Tumor-Associated Antigens In The Course Of Pregnancy As a Model For Immunotherapy

Salvage Therapy with Everolimus Reduces the Severity of Treatment-Refractory Chronic Graft-Versus-Host Disease without Impairing Disease Control: A Dual Center Experience

Immune Responses Against the Tumor-Associated Antigens WT1, MUC-1, PRAME and HER2/Neu in 114 Prospectively Screened Healthy Donors: Effects of Gender and Prior Pregnancy and Implications for Immunotherapy

Email alerts

ASH Publications

American Society of Hematology

Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy

Men Show Significantly Higher T Lymphocyte Mediated Immune Responses Against H-Y Than Multiparous Women: Results from a Cross-Sectional Analysis in 114 Volunteer Blood Donors and Implications for Immunotherapy

Boost and Loss Of Immune Responses Against Tumor-Associated Antigens In The Course Of Pregnancy As a Model For Immunotherapy

Salvage Therapy with Everolimus Reduces the Severity of Treatment-Refractory Chronic Graft-Versus-Host Disease without Impairing Disease Control: A Dual Center Experience

Immune Responses Against the Tumor-Associated Antigens WT1, MUC-1, PRAME and HER2/Neu in 114 Prospectively Screened Healthy Donors: Effects of Gender and Prior Pregnancy and Implications for Immunotherapy

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only